These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25541674)

  • 1. Haptoglobin genotypes polymorphism as a risk factor for subclinical atherosclerosis in beta-thalassemia major children; a single center Egyptian study.
    Ragab SM; Safan MA; Badr EA; Ebeid OM
    Hematology; 2015 Sep; 20(8):477-486. PubMed ID: 25541674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The haptoglobin 2-2 genotype is associated with carotid atherosclerosis in 64-year old women with established diabetes.
    Ryndel M; Behre CJ; Brohall G; Prahl U; Schmidt C; Bergström G; Fagerberg B; Olson FJ
    Clin Chim Acta; 2010 Apr; 411(7-8):500-4. PubMed ID: 20064496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature atherosclerosis in children with beta-thalassemia major: New diagnostic marker.
    Sherief LM; Dawood O; Ali A; Sherbiny HS; Kamal NM; Elshanshory M; Alazez OA; Alhady MA; Nour M; Mokhtar WA
    BMC Pediatr; 2017 Mar; 17(1):69. PubMed ID: 28279156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does haptoglobin genotype affect early onset of diabetic retinopathy in patients with type 2 diabetes?
    Goldenberg-Cohen N; Gabbay M; Dratviman-Storobinsky O; Reich E; Axer-Siegel R; Weinberger D; Gabbay U
    Retina; 2011 Sep; 31(8):1574-80. PubMed ID: 21555971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
    Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
    Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum haptoglobin levels and Hp1-Hp2 polymorphism in the haptoglobin gene in patients with atrial fibrillation.
    Costa LBX; Martins GL; Duarte RCF; Rocha PL; Figueiredo EL; Silveira FR; das Graças Carvalho M; Reis HJ; Gomes KB; Ferreira CN
    Mol Biol Rep; 2022 Aug; 49(8):7359-7365. PubMed ID: 35576050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations.
    Papp M; Foldi I; Nemes E; Udvardy M; Harsfalvi J; Altorjay I; Mate I; Dinya T; Varvolgyi C; Barta Z; Veres G; Lakatos PL; Tumpek J; Toth L; Szathmari E; Kapitany A; Gyetvai A; Korponay-Szabo IR
    Clin Chem; 2008 Apr; 54(4):697-704. PubMed ID: 18258668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype of haptoglobin and presence of subclinical vascular disease: Population study.
    Mostaza JM; de Dios O; Lahoz C; Arribas M; Pérez Arroyo A; Salinero-Fort MA; Laguna F; Estirado E; García-Iglesias F; González Alegre T; Sabín C; López S; Sánchez V; Cornejo V; Garcés C;
    Clin Investig Arterioscler; 2020; 32(1):1-7. PubMed ID: 31221534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of haptoglobin genotype in an Iranian population with idiopathic generalized epilepsy.
    Al-Balaghee S; Al-Balaghee Z; Shabani A; Ghadam P; Bandehpour M; Askari Mehr A; Kazemi B
    Rep Biochem Mol Biol; 2015 Apr; 3(2):51-5. PubMed ID: 26989737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haptoglobin polymorphism in relation to coronary plaque characteristics on radiofrequency intravascular ultrasound and near-infrared spectroscopy in patients with coronary artery disease.
    Buljubasic N; Oemrawsingh RM; Smeets MB; Cheng JM; Regar E; van Geuns RJ; Serruys PW; Boersma E; Akkerhuis KM; Kardys I; Arslan F
    Int J Cardiol; 2016 Oct; 221():682-7. PubMed ID: 27423090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The haptoglobin-gene deletion responsible for anhaptoglobinemia.
    Koda Y; Soejima M; Yoshioka N; Kimura H
    Am J Hum Genet; 1998 Feb; 62(2):245-52. PubMed ID: 9463309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
    Hostettler IC; Morton MJ; Ambler G; Kazmi N; Gaunt T; Wilson D; Shakeshaft C; Jäger HR; Cohen H; Yousry TA; Al-Shahi Salman R; Lip G; Brown MM; Muir K; Houlden H; Bulters DO; Galea I; Werring DJ;
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):298-304. PubMed ID: 31924654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Vitamin E supplementation on vascular function in haptoglobin genotype stratified diabetes patients (EVAS Trial): a randomised controlled trial.
    Dalan R; Goh LL; Lim CJ; Seneviratna A; Liew H; Seow CJ; Xia L; Chew DEK; Leow MKS; Boehm BO
    Nutr Diabetes; 2020 Apr; 10(1):13. PubMed ID: 32341356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemia-modified albumin as a marker of vascular dysfunction and subclinical atherosclerosis in β-thalassemia major.
    Adly AAM; ElSherif NHK; Ismail EAR; Ibrahim YA; Niazi G; Elmetwally SH
    Redox Rep; 2017 Nov; 22(6):430-438. PubMed ID: 28288539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin Gene Polymorphism in Patients with Sickle Cell Anemia: Findings from a Nigerian Cohort Study.
    Olatunya OS; Albuquerque DM; Santos MNN; Kayode TS; Adekile A; Costa FF
    Appl Clin Genet; 2020; 13():107-114. PubMed ID: 32440193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited influence of haptoglobin genotypes on severe malaria in Ghanaian children.
    Bienzle U; Eggelte TA; Adjei LA; Dietz E; Ehrhardt S; Cramer JP; Otchwemah RN; Mockenhaupt FP
    Trop Med Int Health; 2005 Jul; 10(7):668-71. PubMed ID: 15960705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major.
    Awadallah SM; Nimer NA; Atoum MF; Saleh SA
    Clin Chim Acta; 2011 May; 412(11-12):975-9. PubMed ID: 21315066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical atherosclerosis in young beta-thalassemia major patients.
    Tantawy AA; Adly AA; El Maaty MG; Amin SA
    Hemoglobin; 2009; 33(6):463-74. PubMed ID: 19958191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with β-Thalassemia Major.
    Soltani D; Fakhrzadeh H; Sharifi F; Mahmoudi MJ; Mahmoudi E; Vasheghani-Farahani A
    Hemoglobin; 2021 Mar; 45(2):107-111. PubMed ID: 33829939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.